Nonhuman TRIM5 variants enhance recognition of HIV-1-infected cells by CD8+ T cells

Journal of Virology

Volumn 90, Issue 19, 2016, Pages 8552-8562

  Jimenez Moyano, Esther ^a   Ruiz, Alba ^a   Kløverpris, Henrik N ^b   Rodriguez Plata, Maria T ^c   Peña, Ruth ^a   Blondeau, Caroline ^c   Selwood, David L ^d   Izquierdo Useros, Nuria ^a   Moris, Arnaud ^e   Clotet, Bonaventura ^a   Goulder, Philip ^f   Towers, Greg J ^c   Prado, Julia G ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TRIPARTITE MOTIF PROTEIN 5; TRIPARTITE MOTIF PROTEIN 5 CYCLOPHILIN A; UNCLASSIFIED DRUG; CYCLOPHILIN A; PROTEIN; TRIM5(ALPHA) PROTEIN, RHESUS MONKEY;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AOTUS; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHESUS MONKEY; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL LINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYCLOPHILIN A; HIV-1; HUMANS; MACACA MULATTA; PROTEINS;

EID: 84990236132     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00819-16     Document Type: Article

References (42)

1. Ndhlovu ZM, Kamya P, Mewalal N, Kløverpris HN, Nkosi T, Pretorius K, Laher F, Ogunshola F, Chopera D, Shekhar K, Ghebremichael M, Ismail N, Moodley A, Malik A, Leslie A, Goulder PJR, Buus S, Chakraborty A, Dong K, Ndung'u T, Walker BD. 2015. Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point. Immunity 43:591-604. http://dx.doi.org/10.1016/j.immuni.2015.08.012
2. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. 2010. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 10:11-23. http://dx.doi.org/10.1038/nri2674
3. Iwasaki A, Pillai PS. 2014. Innate immunity to influenza virus infection. Nat Rev Immunol 14:315-328. http://dx.doi.org/10.1038/nri3665
4. Sawyer SL, Wu LI, Emerman M, Malik HS. 2005. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 102:2832-2837. http://dx.doi.org/10.1073/pnas.0409853102
5. Sawyer SL, Emerman M, Malik HS. 2004. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2:E275. http://dx.doi.org/10.1371/journal.pbio.0020275
6. Towers GJ. 2007. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 4:40. http://dx.doi.org/10.1186/1742-4690-4-40
7. Fletcher AJ, Christensen DE, Nelson C, Tan CP, Schaller T, Lehner PJ, Sundquist WI, Towers GJ. 2015. TRIM5α requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. EMBO J 34:2078-2095. http://dx.doi.org/10.15252/embj.201490361
8. Rold CJ, Aiken C. 2008. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog 4:e1000074. http://dx.doi.org/10.1371/journal.ppat.1000074
9. Zhao G, Ke D, Vu T, Ahn J, Shah VB, Yang R, Aiken C, Charlton LM, Gronenborn AM, Zhang P. 2011. Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces. PLoS Pathog 7:e1002009. http://dx.doi.org/10.1371/journal.ppat.1002009
10. Pertel T, Hausmann S, Morger D, Züger S, Guerra J, Lascano J, Reinhard C, Santoni FA, Uchil PD, Chatel L, Bisiaux A, Albert ML, Strambio-De-Castillia C, Mothes W, Pizzato M, Grütter MG, Luban J. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-365. http://dx.doi.org/10.1038/nature09976
11. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, Antonarakis SE, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Goldstein DB. 2007. A wholegenome association study of major determinants for host control of HIV-1. Science 317:944-947. http://dx.doi.org/10.1126/science.1143767
12. Goulder PJR, Walker BD. 2012. HIV and HLA class I: an evolving relationship. Immunity 37:426-440. http://dx.doi.org/10.1016/j.immuni.2012.09.005
13. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, Zimbwa P, Moore S, Allen T, Brander C, Addo MM, Altfeld M, James I, Mallal S, Bunce M, Barber LD, Szinger J, Day C, Klenerman P, Mullins J, Korber B, Coovadia HM, Walker BD, Goulder PJR. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769-775. http://dx.doi.org/10.1038/nature03113
14. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, Reddy S, de Pierres C, Mncube Z, Mkhwanazi N, Bishop K, van der Stok M, Nair K, Khan N, Crawford H, Payne R, Leslie A, Prado J, Prendergast A, Frater J, McCarthy N, Brander C, Learn GH, Nickle D, Rousseau C, Coovadia H, Mullins JI, Heckerman D, Walker BD, Goulder P. 2007. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13:46-53. http://dx.doi.org/10.1038/nm1520
15. Sáez-Cirión A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C, Boufassa F, Avettand-Fènoël V, Rouzioux C, Delfraissy J-F, Barré-Sinoussi F, Lambotte O, Venet A, Pancino G, ANRS EP36 HIV Controllers Study Group. 2009. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol 182:7828-7837. http://dx.doi.org/10.4049/jimmunol.0803928
16. Dalmau J, Rotger M, Erkizia I, Rauch A, Reche P, Pino M, Esteve A, Palou E, Brander C, Paredes R, Phung P, Clotet B, Telenti A, Martinez-Picado J, Prado JG, CoRP Study Group. 2014. Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression. AIDS 28:1261-1272. http://dx.doi.org/10.1097/QAD.0000000000000293
17. Prado JG, Honeyborne I, Brierley I, Puertas MC, Martinez-Picado J, Goulder PJR. 2009. Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein. J Virol 83:1018-1025. http://dx.doi.org/10.1128/JVI.01882-08
18. Ayinde D, Bruel T, Cardinaud S, Porrot F, Prado JG, Moris A, Schwartz O. 2015. SAMHD1 limits HIV-1 antigen presentation by monocytederived dendritic cells. J Virol 89:6994-7006. http://dx.doi.org/10.1128/JVI.00069-15
19. Casartelli N, Guivel-Benhassine F, Bouziat R, Brandler S, Schwartz O, Moris A. 2010. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells. J Exp Med 207:39-49. http://dx.doi.org/10.1084/jem.20091933
20. Payne RP, Kløverpris H, Sacha JB, Brumme Z, Brumme C, Buus S, Sims S, Hickling S, Riddell L, Chen F, Luzzi G, Edwards A, Phillips R, Prado JG, Goulder PJ. 2010. Efficacious early antiviral activity of HIV Gag-and Pol-specific HLA-B 2705-restricted CD8+ T cells. J Virol 84: 10543-10557. http://dx.doi.org/10.1128/JVI.00793-10
21. Mattiuzzo G, Rose NJ, Almond N, Towers GJ, Berry N. 2013. Upregulation of TRIM5α gene expression after live-attenuated simian immunodeficiency virus vaccination in Mauritian cynomolgus macaques, but TRIM5α genotype has no impact on virus acquisition or vaccination outcome. J Gen Virol 94:606-611. http://dx.doi.org/10.1099/vir.0.047795-0
22. Carthagena L, Parise MC, Ringeard M, Chelbi-Alix MK, Hazan U, Nisole S. 2008. Implication of TRIMalpha and TRIMCyp in interferoninduced anti-retroviral restriction activities. Retrovirology 5:59. http://dx.doi.org/10.1186/1742-4690-5-59
23. Izquierdo-Useros N, Blanco J, Erkizia I, Fernández-Figueras MT, Borràs FE, Naranjo-Gómez M, Bofill M, Ruiz L, Clotet B, Martinez-Picado J. 2007. Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission. J Virol 81:7559-7570. http://dx.doi.org/10.1128/JVI.02572-06
24. Kløverpris HN, Payne RP, Sacha JB, Rasaiyaah JT, Chen F, Takiguchi M, Yang OO, Towers GJ, Goulder P, Prado JG. 2013. Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells. J Virol 87:2628-2638. http://dx.doi.org/10.1128/JVI.02131-12
25. Lamoreaux L, Roederer M, Koup R. 2006. Intracellular cytokine optimization and standard operating procedure. Nat Protoc 1:1507-1516. http://dx.doi.org/10.1038/nprot.2006.268
26. Izquierdo-Useros N, Lorizate M, Puertas MC, Rodriguez-Plata MT, Zangger N, Erikson E, Pino M, Erkizia I, Glass B, Clotet B, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J. 2012. Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol 10:e1001448. http://dx.doi.org/10.1371/journal.pbio.1001448
27. Nomaguchi M, Nakayama EE, Yokoyama M, Doi N, Igarashi T, Shioda T, Sato H, Adachi A. 2014. Distinct combinations of amino acid substitutions in N-terminal domain of Gag-capsid afford HIV-1 resistance to rhesus TRIM5α. Microbes Infect 16:936-944. http://dx.doi.org/10.1016/j.micinf.2014.08.017
28. Soll SJ, Wilson SJ, Kutluay SB, Hatziioannou T, Bieniasz PD. 2013. Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism. PLoS Pathog 9:e1003667. http://dx.doi.org/10.1371/journal.ppat.1003667
29. Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, Hilditch L, Jacques DA, Selwood DL, James LC, Noursadeghi M, Towers GJ. 2013. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503:402-405. http://dx.doi.org/10.1038/nature12769
30. Neefjes J, Jongsma MLM, Paul P, Bakke O. 2011. Towards a systems understanding ofMHCclass I andMHCclass II antigen presentation. Nat Rev Immunol 11:823-836. http://dx.doi.org/10.1038/nri3084
31. Quinn KM, Zak DE, Costa A, Yamamoto A, Kastenmuller K, Hill BJ, Lynn GM, Darrah PA, Lindsay RWB, Wang L, Cheng C, Nicosia A, Folgori A, Colloca S, Cortese R, Gostick E, Price DA, Gall JGD, Roederer M, Aderem A, Seder RA. 2015. Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. J Clin Invest 125:1129-1146. http://dx.doi.org/10.1172/JCI78280
32. Danielson CM, Cianci GC, Hope TJ. 2012. Recruitment and dynamics of proteasome association with rhTRIM5α cytoplasmic complexes during HIV-1 infection. Traffic 13:1206-1217. http://dx.doi.org/10.1111/j.1600-0854.2012.01381.x
33. Iwasaki A. 2012. Innate immune recognition of HIV-1. Immunity 37: 389-398. http://dx.doi.org/10.1016/j.immuni.2012.08.011
34. Blanco-Melo D, Venkatesh S, Bieniasz PD. 2012. Intrinsic cellular defenses against human immunodeficiency viruses. Immunity 37:399-411. http://dx.doi.org/10.1016/j.immuni.2012.08.013
35. Richardson MW, Guo L, Xin F, Yang X, Riley JL. 2014. Stabilized human TRIM5α protects human T cells from HIV-1 infection. Mol Ther 22:1084-1095. http://dx.doi.org/10.1038/mt.2014.52
36. Magnacca A, Persiconi I, Nurzia E, Caristi S, Meloni F, Barnaba V, Paladini F, Raimondo D, Fiorillo MT, Sorrentino R. 2012. Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules. J Biol Chem 287:30358-30367. http://dx.doi.org/10.1074/jbc. M112.384339
37. Tenzer S, Wee E, Burgevin A, Stewart-Jones G, Friis L, Lamberth K, Chang CH, Harndahl M, Weimershaus M, Gerstoft J, Akkad N, Klenerman P, Fugger L, Jones EY, McMichael AJ, Buus S, Schild H, van Endert P, Iversen AK. 2009. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol 10:636-646. http://dx.doi.org/10.1038/ni.1728
38. Oliveira CC, Querido B, Sluijter M, Derbinski J, van der Burg SH, van Hall T. 2011. Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires. Eur J Immunol 41:3114-3124. http://dx.doi.org/10.1002/eji.201141836
39. Fletcher AJ, Mallery DL, Watkinson RE, Dickson CF, James LC. 2015. Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21. Proc Natl Acad Sci U S A 112:10014-10019. http://dx.doi.org/10.1073/pnas.1507534112
40. Granier C, Battivelli E, Lécuroux C, Venet A, Lambotte O, Schmitt-Boulanger M, Delaugerre C, Molina JM, Chakrabarti LA, Clavel F, Hance AJ. 2013. Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles. J Virol 87: 10368-10380. http://dx.doi.org/10.1128/JVI.01313-13
41. Chan E, Schaller T, Eddaoudi A, Zhan H, Tan CP, Jacobsen M, Thrasher AJ, Towers GJ, Qasim W. 2012. Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor. Hum Gene Ther 23:1176-1185. http://dx.doi.org/10.1089/hum.2012.083
42. Jung U, Urak K, Veillette M, Nepveu-Traversy Mé, Pham QT, Hamel S, Rossi JJ, Berthoux L. 2015. Preclinical assessment of mutant human TRIM5α as an anti-HIV-1 transgene. Hum Gene Ther 26:664-679 http://dx.doi.org/10.1089/hum.2015.059